May 18, 2021 / 08:10PM GMT
Operator
Good day. And welcome to the Qualigen Therapeutics business update conference. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Yvonne Briggs. Please go ahead.
Yvonne Briggs - LHA - IR
Thank you, operator. And good afternoon. This is Yvonne Briggs with LHA. Thank you all for joining Qualigen Therapeutics' business update conference call. Before we begin, I'd like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws.
These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results. For a list and description of risks and uncertainties, please review Qualigen's filings with the SEC.
Importantly, this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast today, August 18, 2020. Except as required by law, Qualigen undertakes no
Q1 2021 Qualigen Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot